CD274 and Marinesco-Sjogren syndrome: Further subgroup analyses showed that the median PFS and OS were 7.8 (95% CI: 5.9-9.7) months and 23.8 (95% CI: 14.3-33.3) months for 25 patients with pMMR/MSS disease and PD-L1 ≥1 (Figures 3E, F), 8.7 (95% CI: 6.9-10.5) months and 26.7 (95% CI: 18.8-34.6) months for 14 patients with pMMR/MSS disease and PD-L1 ≥5 (Figures 3G, H), and 8.8 (95% CI: 7.9-9.7) months and 26.7 (95% CI: 20.8-32.6) months for eight patients with pMMR/MSS disease and PD-L1 ≥10 (Figures 3I, J), respectively.